
David Haslam confirmed as NICE chair
pharmafile | December 18, 2012 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Haslam, Hunt, NICE
David Haslam has been confirmed as chair of the National Institute for Health and Clinical Excellence.
Professor Haslam is currently the National Clinical adviser to the Care Quality Commission, chair of the NICE Evidence Accreditation Advisory Board and an expert member of the NHS National Quality Board.
Haslam will head up NICE, currently a Special Health Authority which will become an Executive Non-Departmental Public Body from 1 April 2013 when it extends its remit to adults’ and children’s social care.
Health secretary Jeremy Hunt said: “I am pleased to confirm David Haslam as chair of the National Institute for Health and Clinical Excellence.
“He will bring to this important role a wealth of skills and experience from his distinguished career as both a front line GP and a respected clinical leader. David is well-qualified to provide strong leadership for NICE’s work to support quality improvement across the health and care system.”
Haslam added: “I am delighted and honoured to have been appointed to be chair of NICE. I sincerely hope that I can build on the remarkable work of Sir Michael Rawlins who has led NICE from its formation to become such an internationally respected and valued organisation.”
Related Content

Combination treatments: Takeda’s Implementation Framework and the broader landscape
Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment …
NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS
Walton Oaks, 21st May 2025 – Pfizer Ltd announced today that the National Institute for Health and Care …

Dual immunotherapy for bowel cancer now available under NHS
Dual immunotherapy, a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), has been granted extension in …






